Module 3 Inactivated poliovirus vaccine eligibility Training for Inactivated Poliovirus Vaccine (IPV) introduction.

Slides:



Advertisements
Similar presentations
Module 4 Rotavirus vaccine administration
Advertisements

Module 4 Rotavirus vaccine administration
Training for rotavirus vaccine introduction
Module 1 Introduction to rotavirus disease and vaccine
Module 3 Rotavirus vaccine eligibility
Training for rotavirus vaccine introduction
Module 3 Rotavirus vaccine eligibility
Training for rotavirus vaccine introduction Module 3 Rotavirus vaccine eligibility.
Module 6 Rotavirus vaccine AEFI monitoring
Module 2 Inactivated poliovirus vaccine (IPV) attributes and storage requirements Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Training for rotavirus vaccine introduction Module 4 Rotavirus vaccine administration.
Module 1 Introduction to the polio endgame rationale and IPV vaccine
Module 6 Inactivated poliovirus vaccine AEFI monitoring Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Poliomyelitis First described by Michael Underwood in 1789 First outbreak described in U.S. in ,000 paralytic cases reported in the U. S. in 1952.
Training for rotavirus vaccine introduction Module 5 Recording and monitoring uptake of rotavirus vaccine.
Orientation on the Rotavirus vaccination
Smallpox Vaccine Contraindications and Screening Department of Health and Human Services Centers for Disease Control and Prevention December 2002 Note:
Adult Immunization 2010 MMR Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010.
Module 5 Recording and monitoring uptake of Inactivated Polio vaccine (IPV) Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Training for rotavirus vaccine introduction Module 3 Rotavirus vaccine eligibility.
Expanded Program of Immunization Dr. Faten M. Rabie.
Polio and Polio Vaccine
Training for rotavirus vaccine introduction Module 7 Communicating about rotavirus vaccine with caretakers.
EPI VACCINES. BCG ( Bacille Calmette- Guerin)  Protects infants against TB  In powder form with diluents  Must be discarded after 6 hrs. or at the.
10/27/2015Immunization schedule1. Immunization M. Emadoleslami MD.
Country Report Progress Toward Strengthening EPI [Country Name]
IMMUNITY IMMYNIZATION IMMUNITY. Active immunity are defenses developed by the body that last many years or even a life time. Active immunity are defenses.
BCG Vaccine Usual reactions induration: 2 – 4 wks pustule formation: 5 – 7 wks scar formation: 2 – 3 months Accelerated Reactions: induration: 2-3 days.
Module 2 Inactivated poliovirus vaccine (IPV) attributes and storage requirements Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Training for rotavirus vaccine introduction Module 1 Introduction to rotavirus disease and vaccine.
Module 4 IPV vaccine administration Training for Inactivated Poliovirus Vaccine (IPV) introduction.
World Health Organization
Module 7 Communicating with parents, caregivers and health personnel about IPV and multiple injections Training for Inactivated Poliovirus Vaccine (IPV)
Module 3 IPV schedule, eligibility and contraindications Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Module 6 Monitoring Events Supposedly Attributable to Vaccination or Immunization (ESAVIs) Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Module 1 Introduction to the polio endgame rationale and IPV vaccine
Module 5 Recording and monitoring administration of the Inactivated Polio Vaccine (IPV) Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Polio and Polio Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control and Prevention.
Vaccination د.رائد كريم العكيلي.
Module 5 Recording and monitoring uptake of rotavirus vaccine
Fractional IPV (fIPV) eligibility
Module 8 Safety and acceptability of multiple injections
Safety and acceptability of multiple injections
Communicating with caregivers about IPV and multiple injections
Communicating with caregivers about IPV and multiple injections
World Health Organization
Recording and monitoring uptake of JE vaccine
World Health Organization
Module 6 Rotavirus vaccine AEFI monitoring
JE vaccine eligibility
World Health Organization
Recording and monitoring uptake of fractional IPV (fIPV)
Module 8 Safety and acceptability of multiple injections
Module 6 Rotavirus vaccine AEFI monitoring
Module 3 Rotavirus vaccine eligibility
Module 5 Recording and monitoring uptake of rotavirus vaccine
Module 6 Rotavirus vaccine AEFI monitoring
Module 6 Rotavirus vaccine AEFI monitoring
Smallpox Vaccine Contraindications and Screening
Module 4 Rotavirus vaccine administration
Module 4 Rotavirus vaccine administration
Module 3 Rotavirus vaccine eligibility
Module 5 Recording and monitoring uptake of rotavirus vaccine
Module 5 Recording and monitoring uptake of rotavirus vaccine
Module 5 Recording and monitoring uptake of rotavirus vaccine
Module 5 Recording and monitoring uptake of rotavirus vaccine
Module 3 Rotavirus vaccine eligibility
Module 6 Rotavirus vaccine AEFI monitoring
World Health Organization
World Health Organization
Presentation transcript:

Module 3 Inactivated poliovirus vaccine eligibility Training for Inactivated Poliovirus Vaccine (IPV) introduction

Inactivated poliovirus vaccine eligibility, Module 3 | 12 July |2 | Learning objectives At the end of the module, the participant will be able to: – Describe the recommended immunization schedule for inactivated poliovirus vaccine (IPV) – Determine when an infant is and is not eligible to receive IPV – Describe ways to determine a child's eligibility for IPV when a written record is unavailable – Describe the absolute contraindications for vaccination Duration – 30 minutes

Inactivated poliovirus vaccine eligibility, Module 3 | 12 July |3 | Key issues What is the recommended schedule for IPV? 1 1 What do you do when the exact date of birth (DOB) or the immunization card is missing? 2 2 What are the contraindications to vaccination? 3 3

Inactivated poliovirus vaccine eligibility, Module 3 | 12 July |4 | Give IPV at or after age 14 weeks, usually with OPV3 and DTP3/Penta3 IPV should be given in addition to OPV OPV is still the primary vaccine to achieve eradication At what age should IPV be administered? Example EPI schedule using DTP-Hib-Hep B (Pentavalent), pneumococcal conjugate (PCV) and rotavirus vaccines IPV should be given at 14 weeks, or at the first contact after 14 weeks VaccineBirth6 wks10 wks14 wks BCG Pentavalent PCV Rotavirus* OPV IPV *rotavirus vaccine may be 2 or 3 doses, depending upon the vaccine used

Inactivated poliovirus vaccine eligibility, Module 3 | 12 July |5 | A child's immunization card shows that he/she is now 18 weeks old and has only received BCG and 2 doses of OPV. What should you do? What should you do in this scenario?

Inactivated poliovirus vaccine eligibility, Module 3 | 12 July |6 | A child's immunization card shows that he/she is now 10 weeks old and has only received BCG and one dose of OPV. What should you do? What should you do in this scenario?

Inactivated poliovirus vaccine eligibility, Module 3 | 12 July |7 | A child comes in at 6 months of age and has had no vaccines. What should you do? What should you do in this scenario?

Inactivated poliovirus vaccine eligibility, Module 3 | 12 July |8 | What should you do in this scenario? A caretaker brings a child to the health center for the first time and comes without any written documentation. The caretaker does not remember the exact date of birth (DOB) of the infant. What are some possible ways of determining the child’s DOB?

Inactivated poliovirus vaccine eligibility, Module 3 | 12 July |9 | Possible ways to estimate the DOB See if the caretaker can recall when the child was born relative to a cultural, religious, national or local event Look for DOB record in other documents kept in the health center or other local registries – Antenatal care record – Birth registry Look for development indicators – A child who can sit unsupported and reach out with one hand is probably old enough to get IPV and other required vaccines

Inactivated poliovirus vaccine eligibility, Module 3 | 12 July | Absolute contraindications to IPV Do not vaccinate if recipient has: Known or documented allergy to vaccine components, including: -Streptomycin -Neomycin -Polymyxin B History of an allergic reaction following a previous IPV injection Thrombocytopenia (insufficient blood platelets, which play an important role in coagulation) Other bleeding disorder Wait! Postpone vaccination if recipient is: Taking temporary treatment that suppresses the immune response -Treatment could reduce immune response to the vaccine -Postpone vaccination until the end of the treatment to make sure the infant is well protected by the vaccine

Inactivated poliovirus vaccine eligibility, Module 3 | 12 July | Can IPV be administered on schedule to immunodeficient infants or infants born prematurely? Yes! Immunodeficiency does not prevent administration of IPV Vaccination of infants with immunodeficiency, such as HIV infection, is recommended Infants born prematurely should receive IPV on schedule (at or after 14 weeks of age)

Inactivated poliovirus vaccine eligibility, Module 3 | 12 July | Contraindication Checklist Do I still give IPV if recipient has….?YesNoPostpone …mild illness …malnutrition …HIV …prematurity …allergy to streptomycin, neomycin or polymyxin B …bleeding disorder …had a previous reaction to IPV …taking treatment that suppresses immune response

Inactivated poliovirus vaccine eligibility, Module 3 | 12 July | Key messages First IPV dose should be given at 14 weeks of age or at first contact after 14 weeks IPV can be given and the same time as other injectable vaccines like pentavalent and pneumococcal vaccine If EPI schedule currently includes OPV, do not replace OPV with IPV; the dose of IPV should be added to the schedule IPV can be administered to children with immunodeficiency disorders and those born prematurely

Inactivated poliovirus vaccine eligibility, Module 3 | 12 July | End of module Thank you for your attention!